HK1098742A1 - Substituted 1h-pyrrolo [3,2-b, 3,2-c, and 2,3-c]pyridine-2-carboxamides and related analogs as inhibitors of casein kinase i epsilon - Google Patents

Substituted 1h-pyrrolo [3,2-b, 3,2-c, and 2,3-c]pyridine-2-carboxamides and related analogs as inhibitors of casein kinase i epsilon

Info

Publication number
HK1098742A1
HK1098742A1 HK07105112.5A HK07105112A HK1098742A1 HK 1098742 A1 HK1098742 A1 HK 1098742A1 HK 07105112 A HK07105112 A HK 07105112A HK 1098742 A1 HK1098742 A1 HK 1098742A1
Authority
HK
Hong Kong
Prior art keywords
inhibitors
compounds
casein kinase
carboxamides
pyrrolo
Prior art date
Application number
HK07105112.5A
Other languages
English (en)
Inventor
William A Metz
Frank Halley
Gilles Dutruc-Rosset
Yong Mi Choi-Sledeski
Gregory B Poli
David M Fink
Gilles Doerflinger
Bao-Guo Huang
Ann Marie Gelormini
Juan A Gamboa
Andrew Giovanni
Joachim E Roehr
Joseph T Tsay
Fernando Camacho
William J Hurst
Stephen W Harnish
Yulin Chiang
Original Assignee
Aventis Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Inc filed Critical Aventis Pharma Inc
Publication of HK1098742A1 publication Critical patent/HK1098742A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
HK07105112.5A 2003-12-11 2007-05-15 Substituted 1h-pyrrolo [3,2-b, 3,2-c, and 2,3-c]pyridine-2-carboxamides and related analogs as inhibitors of casein kinase i epsilon HK1098742A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US52876403P 2003-12-11 2003-12-11
PCT/US2004/040080 WO2005061498A1 (en) 2003-12-11 2004-12-01 Substituted 1h-pyrrolo[3,2-b, 3,2-c, and 2,3-c]pyridine-2-carboxamides and related analogs as inhibitors of casein kinase i epsilon

Publications (1)

Publication Number Publication Date
HK1098742A1 true HK1098742A1 (en) 2007-07-27

Family

ID=34710096

Family Applications (1)

Application Number Title Priority Date Filing Date
HK07105112.5A HK1098742A1 (en) 2003-12-11 2007-05-15 Substituted 1h-pyrrolo [3,2-b, 3,2-c, and 2,3-c]pyridine-2-carboxamides and related analogs as inhibitors of casein kinase i epsilon

Country Status (21)

Country Link
US (2) US7402672B2 (es)
EP (1) EP1747220B1 (es)
JP (1) JP4691506B2 (es)
KR (1) KR20060113754A (es)
CN (1) CN100439367C (es)
AT (1) ATE428711T1 (es)
AU (1) AU2004303826A1 (es)
BR (1) BRPI0417520A (es)
CA (1) CA2549183A1 (es)
DE (1) DE602004020685D1 (es)
DK (1) DK1747220T3 (es)
ES (1) ES2324871T3 (es)
HK (1) HK1098742A1 (es)
HR (1) HRP20090380T1 (es)
IL (1) IL175875A0 (es)
PL (1) PL1747220T3 (es)
PT (1) PT1747220E (es)
RS (1) RS50823B (es)
SI (1) SI1747220T1 (es)
TW (1) TW200530234A (es)
WO (1) WO2005061498A1 (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1791537B1 (en) * 2004-08-19 2009-10-14 Aventis Pharmaceuticals, Inc. 3-arylthioindole-2-carboxamide derivatives and analogs thereof as inhibitors of casein kinase i
JO2629B1 (en) 2004-08-19 2012-06-24 افينتيس فارما سوتيكالز انك Branched carboxylic acid amides containing thienobirol, carboxylic acid amides containing pyrolithiazole, and the like as kinase inhibitors casein epsilon
JO2724B1 (en) * 2004-08-19 2013-09-15 افينتس فارماسوتيكالز انك 3-Alternative-5 -6-Amino Alkyl Indole-2-Carboxyl Acid Amide and Related Isotopes as Casein Kinase Inhibitors
CA2620864A1 (en) * 2005-09-01 2007-03-08 Array Biopharma Inc. Raf inhibitor compounds and methods of use thereof
CA2626742A1 (en) * 2005-10-21 2007-04-26 Exelixis, Inc. Pyrazolo-pyrimidines as casein kinase ii (ck2) modulators
FR2918061B1 (fr) 2007-06-28 2010-10-22 Sanofi Aventis Derives de 6-cycloamino-3-(pyridin-4-yl)imidazo°1,2-b!- pyridazine,leur preparation et leur application en therapeutique.
FR2918986B1 (fr) 2007-07-19 2009-09-04 Sanofi Aventis Sa Derives de 6-cycloamino-3-(pyridazin-4-yl)imidazo[1,2-b]- pyridazine, leur preparation et leur application en therapeutique
FR2939134A1 (fr) 2008-12-01 2010-06-04 Sanofi Aventis Derives de 6-cycloamino-3-(1h-pyrrolo°2,3-b!pyridin-4-yl) imidazo°1,2-b!-pyridazine, leur preparation et leur application en therapeutique
FR2940285A1 (fr) 2008-12-19 2010-06-25 Sanofi Aventis Derives de 6-cycloamino-2-thienyl-3-(pyridin-4-yl)imidazo °1,2-b!-pyridazine et 6-cycloamino-2-furanyl-3- (pyridin-4-yl)imidazo°1,2-b!-pyridazine, leur preparation et leur application en therapeutique
FR2940284B1 (fr) 2008-12-19 2011-02-18 Sanofi Aventis Derives de 6-cycloamino-2,3-di-pyridinyl-imidazo°1,2-b!- pyridazine,leur preparation et leur application en therapeutique
FR2945289A1 (fr) 2009-05-11 2010-11-12 Sanofi Aventis Derives de 2-cycloamino-5-(pyridin-4-yl)imidazo°2,1-b! °1,3,4!thiadiazole, leur preparation et leur application en therapeutique
EP2493876B1 (en) * 2009-10-28 2014-02-12 Pfizer Inc Imidazole derivatives as casein kinase inhibitors
FR2960876B1 (fr) 2010-06-03 2012-07-27 Sanofi Aventis Derives de 3,4-dihydropyrrolo[1,2-a]pyrazine-2,8(1h)-dicarboxamide leur preparation et leur application en therapeutique.
WO2014111871A1 (en) 2013-01-17 2014-07-24 Aurigene Discovery Technologies Limited 4,5-dihydroisoxazole derivatives as nampt inhibitors
KR101657597B1 (ko) * 2013-05-08 2016-09-19 주식회사유한양행 피롤로[2,3-c]피리딘 유도체 또는 이의 약학적으로 허용가능한 염의 제조방법
KR101657599B1 (ko) * 2013-05-20 2016-09-19 주식회사유한양행 피롤로[2,3-c]피리딘 유도체 또는 이의 약학적으로 허용가능한 염의 제조방법
UY35834A (es) * 2013-11-14 2015-05-29 Bristol Myers Squibb Company Una Corporación Del Estado De Delaware Piperazinas de pirazolo sustituido como inhibidores de caseína quinasa 1 delta y epsilon
CN104945313A (zh) * 2015-06-19 2015-09-30 洪帅金 一种2-甲基-3-溴吡啶的制备方法
CN104974082A (zh) * 2015-07-26 2015-10-14 陈吉美 一种2-甲基-4-溴吡啶的制备方法
CN105198802A (zh) * 2015-11-03 2015-12-30 江苏梦得电镀化学品有限公司 一种2-甲基-3-溴吡啶的制备方法
US10973820B2 (en) 2017-12-13 2021-04-13 Facio Intellectual Property B.V. Compounds for treatment of diseases related to DUX4 expression
TW202112368A (zh) 2019-06-13 2021-04-01 荷蘭商法西歐知識產權股份有限公司 用於治療有關dux4表現之疾病的抑制劑組合

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4675332A (en) * 1984-12-10 1987-06-23 Warner-Lambert Company Acidic tetrazolyl substituted indole compounds and their use as antiallergy agents
US5527819A (en) * 1991-09-06 1996-06-18 Merck & Co., Inc. Inhibitors of HIV reverse transcriptase
PL175788B1 (pl) * 1993-02-24 1999-02-26 Merck & Co Inc Amidowe pochodne indolu i zawierające je kompozycje farmaceutyczne
US6075037A (en) 1994-06-09 2000-06-13 Smithkline Beecham Corporation Endothelin receptor antagonists
US5977134A (en) 1996-12-05 1999-11-02 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
US6432989B1 (en) * 1999-08-27 2002-08-13 Pfizer Inc Use of CRF antagonists to treat circadian rhythm disorders
IL160884A0 (en) 2001-10-02 2004-08-31 Upjohn Co Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease
WO2003078435A1 (en) * 2002-03-13 2003-09-25 Pharmacia & Upjohn Company Llc Pyrazolo(1,5-a)pyridine derivatives as neurotransmitter modulators
WO2003080608A2 (en) * 2002-03-27 2003-10-02 Glaxo Group Limited Quinoline and aza-indole derivatives and their use as 5-ht6 ligands

Also Published As

Publication number Publication date
JP2007513950A (ja) 2007-05-31
DK1747220T3 (da) 2009-08-10
KR20060113754A (ko) 2006-11-02
WO2005061498A1 (en) 2005-07-07
CA2549183A1 (en) 2005-07-07
RS50823B (sr) 2010-08-31
US20080200496A1 (en) 2008-08-21
TW200530234A (en) 2005-09-16
CN1906194A (zh) 2007-01-31
CN100439367C (zh) 2008-12-03
ATE428711T1 (de) 2009-05-15
DE602004020685D1 (de) 2009-05-28
HRP20090380T1 (hr) 2009-08-31
IL175875A0 (en) 2006-10-05
EP1747220B1 (en) 2009-04-15
EP1747220A1 (en) 2007-01-31
PT1747220E (pt) 2009-07-08
US20050131012A1 (en) 2005-06-16
PL1747220T3 (pl) 2009-09-30
US7402672B2 (en) 2008-07-22
ES2324871T3 (es) 2009-08-18
AU2004303826A1 (en) 2005-07-07
JP4691506B2 (ja) 2011-06-01
BRPI0417520A (pt) 2007-03-06
SI1747220T1 (sl) 2009-08-31
US7626027B2 (en) 2009-12-01

Similar Documents

Publication Publication Date Title
HK1098742A1 (en) Substituted 1h-pyrrolo [3,2-b, 3,2-c, and 2,3-c]pyridine-2-carboxamides and related analogs as inhibitors of casein kinase i epsilon
ATE365742T1 (de) 4-aminothieno(2,3-d) pyrimidin -6-carbonitril- derivative zur verwendung als pde7 inhibitoren
CY1109558T1 (el) Παραγωγα βενζο[d]αζεπινης για την θεραπεια νευρολογικων διαταραχων
MX337817B (es) Pirazolo [1,5-a] pirimidinas de utilidad como inhibidores de proteina quinasas.
IL187438A0 (en) Pyrrolopyridine derivatives and pharmaceutical compositions containing the same
BG108207A (en) Cyclopropylindole derivatives as selective serotonin reuptake inhibitors
TW200730525A (en) Therapeutic agents
RS20050041A (en) Azaindole kinase inhibitors
IL172419A0 (en) Piperazine derivatives and methods of use
MY140872A (en) 5,7-diaminopyrazolo[4,3-d]pyrimidines with pde-5 inhibitory activity, compositions containing such derivatives and the use of such derivatives in the treatment of hypertension and other disorders
ATE424402T1 (de) Imidazopyridinverbindungen
YU14003A (sh) Biciklična heterociklična jedinjenja, lekovi koji sadrže ova jedinjenja, njihova primena i postupak za njihovo dobijanje
MY139831A (en) Substituted thienopyrrole carboxylic acid amides, pyrrolothiazole carboxylic acid amides, and related analogs as inhibitors of casein kinase i( )
HUP0402270A2 (hu) [1,2,4]Triazolo[1,5-c]pirimidin-5-il-aminok mint adenozin A2a receptor antagonisták és az ezeket tartalmazó gyógyszerkészítmények
GB0112348D0 (en) Compounds
MX2010006748A (es) Pirazolo[1,5-a]pirimidinas utiles como inhibidores de jak2.
PT828728E (pt) Di-hidrobenzofuranos de fenilo
DE60205455D1 (de) Naphthyridinderivate
TW200509933A (en) Therapeutic agents
MY128241A (en) Substituted tetracyclic pyrroloquinolone derivatives useful as phosphodiesterase inhibitors
WO2005062992A3 (en) Substituted melatonin derivatives, process for their preparation, and methods of use
TW200621711A (en) 3-substituted-5- and 6-aminoalkyl indole-2-carboxylic acid amides and related analogs as inhibitors of casein kinase I ε
SE0100297D0 (sv) New compounds
SE0100296D0 (sv) New compounds
SE0100295D0 (sv) New compounds

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20121201